Know Labs, Inc. (KNW)
| Market Cap | 56.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -20.70M |
| Shares Out | 85.51M |
| EPS (ttm) | -0.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,058 |
| Open | 0.700 |
| Previous Close | 0.651 |
| Day's Range | 0.657 - 0.700 |
| 52-Week Range | 0.230 - 1.480 |
| Beta | 1.54 |
| Analysts | Buy |
| Price Target | 1.00 (+51.54%) |
| Earnings Date | May 15, 2024 |
About KNW
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in ... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for KNW stock is "Buy" and the 12-month stock price forecast is $1.0.
News
Know Labs Appoints Chris Somogyi as President, International
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, Interna...
Know Labs, Inc. Reports Second Quarter FY 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal...
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentat...
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster present...
Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced interim results from its most recent clinical resea...
Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development Initiatives
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an inve...
Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU™, its wearable non-invasive continuous gl...
Know Labs, Inc. Reports First Quarter FY2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended Decemb...
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...
Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the company will be exhibiting at the International...
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...
Know Labs Expands Medical and Scientific Advisory Board
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of four new members to the Company'...
Know Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...
Know Labs Expands Board of Directors
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the Company...
Know Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past Year
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, will present at the third annual Bernstein CGM Disruptors Conferenc...
Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment un...
Know Labs, Inc. Reports Third Quarter FY2023 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter ended June 3...
Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...
Know Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) today announced results from a new study titled, “Novel data preprocessing techniques in an expanded dataset improve machine learning mod...
Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
SEATTLE--(BUSINESS WIRE)--Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ t...
Know Labs' Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) today announced the results of a new study titled, “Algorithm Refinement in the Non-Invasive Detection of Blood Glucose Using Know Labs' ...
Know Labs, Inc. Discusses Significant Growth of Its IP Portfolio and 2023 Goals with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - May 25, 2023) - The Stock Day Podcast welcomed Know Labs, Inc. (NYSE American: KNW) ("the Company"), an emerging developer of non-invasive medical diagnostic techno...
Know Labs Joins IPBC Global 2023 to Discuss the Importance of Strategic IP Development in Maximizing Shareholder Value
SEATTLE--(BUSINESS WIRE)--Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced that Pete Conley, its Chief Financial Officer and Senior ...
Know Labs Furthers External Validation of Bio-RFID™ Technology with Study Published in Sensors Journal
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the publication of its first peer-reviewed study in...